CT perfusion and angiography failed to meet sensitivity and specificity thresholds to determine brain death. Neither should be used as standalone tests to establish death by neurologic criteria, the ...
GammaTile treatment reduces tumor recurrence or death risk by over 50% compared to standard care in operable brain metastases. More than half of GammaTile-treated patients were free from tumor ...
CT perfusion and CT angiography did not meet sensitivity and specificity thresholds of 98% to determine death by neurologic criteria (commonly referred to as brain death), a cohort study showed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results